Two-thirds ED Visits for Low-Risk PE Admitted Unnecessarily
Nearly two thirds of ED visits by patients with acute pulmonary embolism resulted in unnecessary hospitalization, suggested a new study.
Source: medscape.com
Severity Indices News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Severity Indices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Severity Indices Today - Breaking & Trending Today
Experimental Topical Drug Shows Promise for AD, Psoriasis
In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.
Source: medscape.com
Novel Subcutaneous Biologics Show Promise in AD
Patients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials.
Source: medscape.com
Nail Psoriasis in Black Patients Often Overlooked
Underrepresentation of Black patients with psoriasis in trials and textbooks might partially explain why clinicians are slow to recognize nail involvement, even after psoriasis has been diagnosed.
Source: medscape.com
Lebrikizumab Gets the Nod for Treating Moderate-to-Severe Atopic Dermatitis in Europe
Lebrikizumab, an interleukin-13 inhibitor, is not yet approved in the United States.
Source: medscape.com